Dyne Therapeutics, Inc. Common Stock (DYN) is a publicly traded Healthcare sector company. As of September 8, 2026, DYN trades at $19.00 with a market cap of $4.53B and a P/E ratio of -7.00. DYN moved -22.63% today. Year to date, DYN is +24.13%; over the trailing twelve months it is +70.75%. Its 52-week range spans $6.36 to $27.31. Analyst consensus is strong buy with an average price target of $41.90. Rallies surfaces DYN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks DYN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $19.00 |
| Market Cap | $4.53B |
| P/E Ratio | -7.00 |
| EPS | $-3.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.31 |
| 52-Week Low | $6.36 |
| Volume | 3.19M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-446.21M |
| Gross Margin | 0.00% |
13 analysts cover DYN: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.90.